retatrutide tachycardia 🔬 — why cardiology and the gym are paying attention For years, peptides lived in bro science or medicine — rarely both. TRIUMPH-4 (Phase 3) changed that. Topline signals: • ~30% tirzepatide or retatrutide Semaglutide vs

Retatrutides triple-agonist approach represents one direction, while quadruple-agonists and amylin-combination peptides like CagriSema are advancing through clinical trials for 2026 and beyond

There are now three pathways for cardiometabolic indications: Type 2 diabetes

Both rates fall below semaglutides 11% discontinuation rate, reinforcing the tolerability advantage of dual and triple agonist approaches

We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease

Whats the best way to track progress beyond the scale

day of the week matters more than hour A 4-hour shift in injection time on a given week has essentially no measurable effect on the weekly dosing curve